# Nanoco Group PLC See significant increase in billings

- Link: https://www.directorstalkinterviews.com/nanoco-group-plc-see-significant-increase-in-billings/412759954
- Published: 2018-10-16T07:28:57+01:00
- Author: Giles Arbor

**[Nanoco Group plc](https://www.directorstalkinterviews.com/company/nanoco-group-plc/nano.l)**(
[LON:NANO](https://www.directorstalkinterviews.com/company/nanoco-group-plc/nano.l)),
a world leader in the development and manufacture of cadmium-free quantum dots and
other specific nanomaterials emanating from our technology platform, has today announced
its preliminary results for the year ended 31 July 2018.

**Operational highlights**

The Group’s nano-material platform technology supports opportunities across a wide
range of markets and end-user applications. Recent performance in a number of these
is summarised below:

Nano-materials (for use in the electronics industry)1

· Excellent progress in the execution of material development and supply agreements
with undisclosed US Company

· £2.6 million received in milestone payments and fees from these contracts during
the year

· Development of new manufacturing facilities in Runcorn, funded by £2.9 million
advance payments by US Company against discounted future product sales

· Expansion project on track to complete by 31 December 2018

· Exploring further revenue generating commercial service opportunities in advance
of product sales

**Display**

· R&D activity changed focus during the year to improve dot performance in line 
with ever increasing technical requirements of the display industry

· Internal development and production resources pivoted away from Display to focus
on the immediate nano-materials opportunity in the electronics market (noted above)

· Progress in Display continues to be hampered by the slow pace of market evolution

· Working with Wah Hong to provide film to a Taiwanese display panel maker targeting
the gaming monitor niche. Revised customer launch date pushes back sales, previously
expected in the 2018 Christmas holiday season

**Lighting**

· Continue to explore a number of specialist applications in the UK and US, specifically
targeting commercial vertical farms for vegetables and sports turf

· CareWear® (one of Carewear Corp’s products) gaining early traction in the US

**Life sciences**

· Further progress in exploring potential uses of the Company’s CFQD technology 
for imaging and diagnosis of cancer

· Initial toxicology tests passed successfully

**Financial highlights**

· Significant increase in billings to £6.5 million (2017: £1.1 million)

· Revenue and other operating income more than doubled to £3.5 million (2017: £1.6
million)

· Loss after tax cut to £6.0 million (2017: £9.1 million) with £1.5 million full-
year benefit of prior year cost reductions

· £7.9 million net proceeds from November 2017 fundraise

· Cash position increased to £10.7 million (31 January 2018: £8.7 million; 31 July
2017: £5.7 million), sufficient to fund Group assuming commercial production revenues
early in H1 FY20. Cash includes an amount of £0.8 million received from a customer
for the purchase of capital equipment. The cash cannot be used for any other purpose.

· Contingency plans in place to reduce costs and preserve cash in event of further
delays to commercial revenue streams.

1 The Group’s platform technology is built on nano-materials. Nano-materials for
use in the electronics industry are one subset of that platform. CFQD® quantum dots
are another subset.

> **Dr Christopher Richards, Nanoco Group plc Chairman, commented on the results:**
> “The last year has clearly shown the benefits of Nanoco’s technological leadership,
> with some potentially very attractive commercial opportunities emerging in the
> short term. The rapid re-deployment of our internal resources to focus on emerging
> and attractive nano-materials opportunities demonstrates our agility and the strength
> of the Group’s technology platform, which allows us to respond quickly to our 
> existing customers and to new unmet needs and opportunities that are emerging.
> Our challenge is to execute and deliver on those opportunities within the constraints
> of our current resource base. The Executive team is alert to the potential of 
> further delays in the realisation of those opportunities and contingency plans
> are in place to manage further delays to our commercial development.
> While there are still hurdles to overcome and a degree of uncertainty to be navigated,
> the Group is currently actively engaged in potentially transformative technological
> and commercial activities. The Board is therefore confident about the relevance
> of our technology and excited about the prospects for the Group in both the short
> and the long term.”

Share on:
